Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 678 · page 1 of 2 of this heading
AASI for Anxiety, Depression, and Related Conditions PATH
(Updated 08/26/2026)
AME Assisted Special Issuance (AASI) is a process that provides AMEs the ability to re-issue an
airman medical certificate under the provisions of an Authorization for Special Issuance of a Medical
Certificate (Authorization) to an applicant who has a medical condition that is disqualifying under Title
14 of the Code of Federal Regulations (14 CFR) part 67.
An FAA physician provides the initial certification decision and grants the Authorization in accordance
with 14 CFR § 67.401. The Authorization letter is accompanied by attachments that specify the
information that the treating physician(s) must provide for the re-issuance determination. If this is a
first-time application for an AASI for the above disease/condition, and the applicant has all the requisite
medical information necessary for a determination, the AME must defer and submit all the
documentation to the AMCD or RFS for the initial determination.
AMEs may re-issue an airman medical certificate under the provisions of an Authorization, if the
applicant provides all the following:
1. An Authorization granted by the FAA which states that AASI PATH has been approved;
2. All interim Detailed Clinical Progress Notes (DCPN). At a MINIMUM, this must include:
a. EVERY 6 months (or more often as clinically indicated), progress notes from a clinic
visit with a treating physician (MD/DO) or extender (PA-C/NP/midlevel);
b. At least one of these 6-month visits (and corresponding progress note) must come
from a physician (MD/DO), such as a Primary Care Physician or Psychiatrist.
c. The most recent clinical progress note must be no more than 90 days before the AME
exam;
d. Detailed Clinical Progress Notes must include a detailed interim summary; current
medications, dosages, and side effects (if any); any changes in medication dose or type
since last visit; physical exam findings; results of all testing performed; diagnosis;
assessment and plan (prognosis); and follow-up; and
3. Anxiety, Depression, and Related Conditions PATH Status Summary completed by the
treating physician and AME.
AME must defer and describe in Block 60 what item(s) caused the deferral if the psychiatrist, treating
physician, or AME identifies any of the following:
• Any NEW “Yes*” answers on the PATH Status Summary;
• Any new (or not previously reported) psychiatric symptoms, signs, or diagnosis;
• Any new history of substance use disorder or FAA substance dependence;
• Any progression (change in symptoms that persist despite modifications to medication and/or
therapy) of the disease; and/or
• AME, treating physician, or treating provider has concerns.
The AME must notify the FAA Aeromedical Certification Division (405-954-4821) if there is a significant
clinical deterioration in my client's cognition, judgment, emotional stability, or insight.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source. Types such as “Special issuance” are reading aids; AME Copilot does not make certification decisions.